ARCH Venture Partners
Venture Capital
Deep Science & Academic Spinouts
Seed
Early Stage
Deep Tech
- Headquarters
- Chicago, United States
- Website
- archventure.com
- AUM
- $9.4B
- Portfolio Companies
- 129
- Last Investment
- Jan 2026
- Geographic Focus
- United States
Investment Thesis
Co-founds and backs deep science companies at the earliest stages, partnering directly with university researchers and scientists to commercialize breakthrough discoveries in life sciences, biotech, and deep tech.
Portfolio129
O
ONIMA
Moleculent ABWB
Walden Biosciences
MB
Magnet BiomedicineLD
Lightcast DiscoveryJT
Juno Therapeutics
LT
Lilac TherapeuticsCB
Cytrellis Biosystems
LI
Lifordi ImmunotherapeuticsI
Illumina
S
SonoTheraBB
BE BiopharmaCT
City TherapeuticsR
RhyGazeAB
Arsenal Biosciences
E
EnumerixQB
Qihan BiotechPT
Pheast Therapeutics
TH
Transcenta HoldingRT
Remix TherapeuticsRB
Reactive Biosciences